Skip to content

A comparative clinical study of dantyadi gutika along with yoga intervention in the management of scanty and delayed menses.

A comparative clinical study of dantyadi gutika along with yoga intervention in the management of artavkshaya w.s.r. oligo-hypomenorhhoea.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031891
Enrollment
40
Registered
2021-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: Dantyadi gutika: Dosage- Two Tablet of Dantyadi Gutika (weighing 500mg each) twice a day for 3 consecutive cycles with gap of 5 days from start of menstruation. Intervention2: Dantyadi

Sponsors

State Ayurvedic college and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling cardinal symptoms of Artavakshaya mention in ayurvedic classic. 2.Patients between the age group of 18-40 years. 3.Patients willing to participate in the study with proper written consent.

Exclusion criteria

Exclusion criteria: 1.Patient having systemic diseases which interfere with the present study(HTN,TB, DM, Thyroid disorder and Hyperprolactenamia) 2.Pregnant & Lactating women. 3.Patient on OCPs, IUCD. 4.Congenital anomalies of uterus or ovaries. 5.Patient with any pelvic pathology or malignancy. 6.Hb% less than 8 gm%.

Design outcomes

Primary

MeasureTime frame
1. To assess the efficacy of Dantyadi gutika along with Yoga Intervention in the Management of Artavakshaya. 2. To assess the efficacy of trial therapy on subjective parameters like Interval between two cycles, Duration of Bleeding, Amount of blood loss, Grade of pain ââ?¬â?? assess with the help of VAS scale and Objective parameters like Hb%, ESR, LFT, USG.Timepoint: Final assessment will be done after completion of trial of 4 consecutive menstrual cycles.

Secondary

MeasureTime frame
To assess the efficacy of trial therapy on subjective parameters like Interval between two cycles, Duration of Bleeding, Amount of blood loss, Grade of pain ââ?¬â?? assess with the help of VAS scale.Timepoint: follow up - each menstrual cycle after the clearance of menses during trial.

Countries

India

Contacts

Public ContactDr Simran

State Ayurvedic college and hospital, Lucknow

bedar.shashi@gmail.com8795545443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026